Key Considerations in Gene Therapy Manufacturing for Commercialization, 2018 – Cell Culture DISH(1) Phase 1 Clinical Study: 18 month (breakthrough), Several months (Traditional BLA)(2) Decision on BT Application: – (BT), N/A (TD)(3) EOP 1 Meeting Confirms BT Therapy Study: 6 months (BT), N/A (TD)(4) Phase 2/3 Clinical Study: 24 months (BT), P2:Several Mo. to 2y and P3:1 to 4y (TD)(5) ・・・
…(閲覧できる本文はここまでです.続きは無料登録でご覧いただけます)